75 related articles for article (PubMed ID: 32682366)
1. Nanostructured Lipid Carriers (NLCs): Nose-to-Brain Delivery and Theranostic Application.
Ahmad J; Rizwanullah M; Amin S; Warsi MH; Ahmad MZ; Barkat MA
Curr Drug Metab; 2020; 21(14):1136-1143. PubMed ID: 32682366
[TBL] [Abstract][Full Text] [Related]
2. Navigating the Nose-to-Brain Route: A Systematic Review on Lipid-Based Nanocarriers for Central Nervous System Disorders.
Agosti E; Zeppieri M; Antonietti S; Battaglia L; Ius T; Gagliano C; Fontanella MM; Panciani PP
Pharmaceutics; 2024 Feb; 16(3):. PubMed ID: 38543223
[TBL] [Abstract][Full Text] [Related]
3. Nanostructured Lipid Carriers (NLCs) as Effective Drug Delivery Systems: Methods of Preparation and their Therapeutic Applications.
Alatawi HM; Alhwiti SS; Alsharif KA; Albalawi SS; Abusaleh SM; Sror GK; Qushawy M
Recent Pat Nanotechnol; 2024; 18(2):179-189. PubMed ID: 38197417
[TBL] [Abstract][Full Text] [Related]
4. Nanostructured Lipid Carriers of Donepezil Hydrochloride for the Treatment of Alzheimer's Disease.
Tekade A; Susar R; Kulkarni G; Surwade S; Gaikwad A
Curr Alzheimer Res; 2024 Mar; ():. PubMed ID: 38445703
[TBL] [Abstract][Full Text] [Related]
5. Nano Lipid Carriers as a Promising Drug Delivery Carrier for Neurodegenerative Disorders - An Overview of Recent Advances.
Kumar V; Nair SC
Recent Pat Biotechnol; 2024; 18(1):2-21. PubMed ID: 38205772
[TBL] [Abstract][Full Text] [Related]
6. Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases.
Tapeinos C; Battaglini M; Ciofani G
J Control Release; 2017 Oct; 264():306-332. PubMed ID: 28844756
[TBL] [Abstract][Full Text] [Related]
7. Nanostructured lipid carriers (NLCs): A promising candidate for lung cancer targeting.
Rajoriya V; Gupta R; Vengurlekar S; Surendra Singh U
Int J Pharm; 2024 Apr; 655():123986. PubMed ID: 38493842
[TBL] [Abstract][Full Text] [Related]
8. Effective Delivery Routes And Strategies For Solid Lipid Nanoparticles (Sln) And Nanostructured Lipid Carriers (Nlc).
Shastri DH
Curr Pharm Des; 2017 Nov; ():. PubMed ID: 29173154
[TBL] [Abstract][Full Text] [Related]
9. Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies.
Elmowafy M; Al-Sanea MM
Saudi Pharm J; 2021 Sep; 29(9):999-1012. PubMed ID: 34588846
[TBL] [Abstract][Full Text] [Related]
10. Nose to Brain Delivery of Phenytoin Sodium Loaded Nano Lipid Carriers: Formulation, Drug Release, Permeation and In Vivo Pharmacokinetic Studies.
Nair SC; Vinayan KP; Mangalathillam S
Pharmaceutics; 2021 Oct; 13(10):. PubMed ID: 34683933
[TBL] [Abstract][Full Text] [Related]
11. Intranasal Administration of a Polymeric Biodegradable Film to C57BL/6 Mice.
Balafas EG; Papakyriakopoulou PI; Kostomitsopoulos NG; Valsami GN
J Am Assoc Lab Anim Sci; 2023 Mar; 62(2):179-184. PubMed ID: 36898691
[TBL] [Abstract][Full Text] [Related]
12. Advances and future perspectives of intranasal drug delivery: A scientometric review.
Xu D; Song XJ; Chen X; Wang JW; Cui YL
J Control Release; 2024 Mar; 367():366-384. PubMed ID: 38286336
[TBL] [Abstract][Full Text] [Related]
13. Understanding the immunogenicity and antigenicity of nanomaterials: Past, present and future.
Ilinskaya AN; Dobrovolskaia MA
Toxicol Appl Pharmacol; 2016 May; 299():70-7. PubMed ID: 26773813
[TBL] [Abstract][Full Text] [Related]
14. Solid Lipid Nanoparticles and Nanostructured Lipid Carriers as Smart Drug Delivery Systems in the Treatment of Glioblastoma Multiforme.
Jnaidi R; Almeida AJ; Gonçalves LM
Pharmaceutics; 2020 Sep; 12(9):. PubMed ID: 32927610
[TBL] [Abstract][Full Text] [Related]
15. Effect of Cerebrospinal Fluid Circulation on Nose-to-Brain Direct Delivery and Distribution of Caffeine in Rats.
Inoue D; Furubayashi T; Tanaka A; Sakane T; Sugano K
Mol Pharm; 2020 Nov; 17(11):4067-4076. PubMed ID: 32955898
[TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of nanostructured lipid carriers, solid lipid nanoparticles and nanoemulsions: A current overview of
Costa CP; Moreira JN; Sousa Lobo JM; Silva AC
Acta Pharm Sin B; 2021 Apr; 11(4):925-940. PubMed ID: 33996407
[TBL] [Abstract][Full Text] [Related]
17. Improving Drug Delivery for Alzheimer's Disease Through Nose-to-Brain Delivery Using Nanoemulsions, Nanostructured Lipid Carriers (NLC) and in situ Hydrogels.
Cunha S; Forbes B; Sousa Lobo JM; Silva AC
Int J Nanomedicine; 2021; 16():4373-4390. PubMed ID: 34234432
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
